Tobin Juvenal sold $240K of Castle Biosciences stock
By AlphaYouPublished Form 4
Juvenal Tobin W
Reporting filer
Tobin Juvenal reported selling 6,578 shares of Castle Biosciences Inc for about $240K ($36.42 a share on average). Form 4 filed Oct 30, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Oct 30, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Juvenal Tobin W | 2026-10-28 | S | Sale | 1237 | 35.577 | 44,194 | 2 days | Filed terms
|
| Common Stock | Juvenal Tobin W | 2026-10-28 | S | Sale | 5341 | 36.619 | 38,853 | 2 days | Filed terms
|
Common Stock
- Owner
- Juvenal Tobin W
- Date
- 2026-10-28
- Code
- S
- Action
- Sale
- Quantity
- 1237
- Price
- 35.577
- Following holdings
- 44,194
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-28
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1237
- transaction Price Per Share: 35.577
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 44194
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Juvenal Tobin W
- Date
- 2026-10-28
- Code
- S
- Action
- Sale
- Quantity
- 5341
- Price
- 36.619
- Following holdings
- 38,853
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-28
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 5341
- transaction Price Per Share: 36.619
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 38853
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Juvenal Tobin W: Chief Commercial Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 28, 2026.
- F2: This transaction was executed in multiple trades at prices ranging from $35.050 to $35.833, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3: This transaction was executed in multiple trades at prices ranging from $36.085 to $36.890, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Original sources
Prepared automatically from public filing data. Report a correction.